TFT Interpretation

The Hypothalamic-Pituitary-Thyroid (HPT) Axis

The interpretation of thyroid function tests (TFTs) is entirely dependent on understanding the Hypothalamic-Pituitary-Thyroid (HPT) axis. This system operates on a classic negative feedback loop:

Hypothalamus releases Thyrotropin-Releasing Hormone (TRH).
TRH stimulates the Anterior Pituitary to release Thyroid-Stimulating Hormone (TSH).
TSH stimulates the Thyroid Gland to produce and release Thyroxine (T4) and Triiodothyronine (T3).
T4 and T3 circulate in the blood (mostly bound to proteins) and exert negative feedback on both the pituitary and the hypothalamus, suppressing TSH and TRH release, respectively.

Because of this feedback, TSH is the most sensitive marker for primary thyroid dysfunction. A small change in free T4 (FT4) leads to a large, logarithmic change in TSH.

The Key Thyroid Tests

TSH (Thyroid-Stimulating Hormone): The single best screening test for thyroid dysfunction in ambulatory patients.
FT4 (Free Thyroxine): Measures the metabolically active, unbound portion of T4. It reflects the thyroid gland's output. Total T4 (TT4) is less reliable as it is affected by changes in binding proteins (e.g., in pregnancy or with oral contraceptive use).
FT3 (Free Triiodothyronine): Measures the active, unbound T3. T3 is the more potent hormone, mostly derived from peripheral conversion of T4. It is primarily useful for diagnosing hyperthyroidism (thyrotoxicosis), as it can be elevated earlier or more significantly than FT4 (known as T3-toxicosis).
Thyroid Antibodies:
- TPOAb (Thyroid Peroxidase Antibodies): A marker of autoimmune thyroid damage. Its presence is diagnostic for Hashimoto's thyroiditis (the most common cause of primary hypothyroidism) and is also found in a majority of patients with Graves' disease.
- TRAb (TSH Receptor Antibodies): These are diagnostic for Graves' disease. They can be stimulating (causing hyperthyroidism) or, rarely, blocking (causing hypothyroidism).
- TgAb (Thyroglobulin Antibodies): Primarily used as a follow-up marker for differentiated thyroid cancer after thyroidectomy and radioiodine ablation. Their presence can also interfere with Thyroglobulin (Tg) assays.

Common Patterns of Thyroid Function Tests

Interpretation relies on matching the TSH and FT4 results.

TSH	Free T4 (FT4)	Free T3 (FT3)	Interpretation	Common Causes
High	Low	Low / Normal	Overt Primary Hypothyroidism	Hashimoto's thyroiditis, post-thyroidectomy, radioiodine therapy, drug-induced (e.g., Lithium).
High	Normal	Normal	Subclinical Hypothyroidism	Early Hashimoto's, insufficient levothyroxine replacement.
Low	High	High / Normal	Overt Primary Hyperthyroidism (Thyrotoxicosis)	Graves' disease, toxic multinodular goiter (MNG), toxic adenoma, thyroiditis (destructive phase).
Low	Normal	High	T3-Toxicosis	Early Graves' disease, toxic MNG.
Low	Normal	Normal	Subclinical Hyperthyroidism	Graves', MNG, over-replacement with levothyroxine.
Low	Low	Low / Normal	Central Hypothyroidism	Pituitary mass (e.g., adenoma), Sheehan's syndrome, infiltrative disease, severe illness (NTI), suppressive drugs (e.g., glucocorticoids, dopamine).
High / Normal	High	High	Secondary Hyperthyroidism	TSH-secreting pituitary adenoma (TSH-oma), thyroid hormone resistance.
Normal	Normal	Normal	Euthyroid	Healthy individual.

Key Clinical Scenarios and Confounders

Interpreting TFTs requires clinical context, as several conditions and substances can alter the results.

1. Non-Thyroidal Illness (NTI)

Also known as Euthyroid Sick Syndrome, this is a critical consideration in hospitalized or critically ill patients.

Pathophysiology: An adaptive response to illness, starvation, or stress, not a true thyroid disorder. It involves altered peripheral deiodinase activity and suppressed TSH.
Classic Pattern:
- Mild/Moderate Illness: Low FT3 (and low Total T3) is the earliest and most common finding, due to decreased conversion of T4 to T3. TSH and FT4 are often normal.
- Severe Illness: Low FT3, Low FT4, and Low/Normal TSH. The TSH is "inappropriately normal" or low for the low FT4 level, mimicking central hypothyroidism.
- Recovery Phase: As the patient recovers, TSH may transiently rise (sometimes >20 mIU/L) before FT4 normalizes.
Routine TFT screening in hospitalized patients is discouraged. Reverse T3 (rT3) is typically high in NTI (due to reduced clearance), whereas it is low in central hypothyroidism, but this test is rarely used.

2. Drug Interference

Many common medications can interfere with TFTs.

Amiodarone: Due to its high iodine content and direct cellular toxicity, it can cause:
- Amiodarone-Induced Hypothyroidism (AIH): More common in iodine-sufficient areas (Wolff-Chaikoff effect^[1]).
- Amiodarone-Induced Thyrotoxicosis (AIT): Type 1 (Jod-Basedow effect^[2] in underlying thyroid disease) or Type 2 (destructive thyroiditis).
Glucocorticoids (high dose) & Dopamine: These drugs suppress TSH secretion, leading to a pattern of central hypothyroidism (Low TSH, Low FT4).
Lithium: Can cause goiter and primary hypothyroidism by inhibiting thyroid hormone release.
Biotin (Vitamin B7): This is a major source of assay interference, not a physiological effect. High doses of biotin (common in hair/nail supplements) interfere with streptavidin-biotin-based immunoassays.
- Typical Interference: Falsely Low TSH and Falsely High FT4/FT3. This pattern dangerously mimics Graves' disease.
- Action: Biotin should be stopped for at least 48 hours (or longer) before thyroid testing.

3. Pregnancy

Thyroid physiology changes significantly during pregnancy.

First Trimester: High hCG levels weakly stimulate the TSH receptor, causing a physiologic suppression of TSH and a slight rise in FT4.
Second/Third Trimester: Estrogen increases Thyroxine-Binding Globulin (TBG), which raises Total T4 (but FT4 remains relatively stable).
Key Point: Trimester-specific reference ranges for TSH must be used for all pregnant patients.

The Wolff-Chaikoff effect is an auto-regulatory mechanism where high levels of circulating iodide cause a temporary inhibition of thyroid hormone synthesis. It occurs because the excess iodide prevents the organification of iodine, effectively "shutting down" the production of T3 and T4 to prevent hyperthyroidism. This effect is usually transient, as the gland typically "escapes" the inhibition after 10 to 14 days by downregulating the sodium-iodide symporter. ↩︎
The Jod-Basedow effect is a form of iodine-induced hyperthyroidism that occurs when a sudden increase in iodine intake triggers excessive hormone production in a predisposed thyroid. It typically affects individuals with underlying conditions like multi-nodular goiter or Graves' disease, where parts of the gland operate autonomously and lack the normal regulatory "shut-off" mechanisms. Unlike the Wolff-Chaikoff effect, which causes a temporary drop in hormone levels, the Jod-Basedow effect results in a sustained, overactive state. ↩︎